Generics Maker Suffers Blow In Eye Drug Ruling

Law360, New York (January 4, 2006, 12:00 AM EST) -- Canadian generic drug maker Apotex received a blow in a court ruling that struck down plans by the company to manufacture a version of Acular, the world’s leading itchy eye treatment.

The temporary restraining order is the latest development in a patent infringement lawsuit over Acular, an anti-inflammatory eye medicine introduced in 1993 by Allergan Inc.

The ruling, issued Dec. 29, prevents Apotex, Apotex Corp. and Novex Pharma from making or selling a generic version of Acular. It comes as the aging U.S. population increases its...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.